Nimotuzumab Completed Phase 3 Trials for Adult Glioblastoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00753246Nimotuzumab in Adults With Glioblastoma Multiforma